The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
about
Electrocortical effects of MDMA are potentiated by acoustic stimulation in ratsChronic exposure to MDMA (Ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants.Illicit stimulant use is associated with abnormal substantia nigra morphology in humansMethanandamide attenuates cocaine-induced hyperthermia in rats by a cannabinoid CB1-dopamine D2 receptor mechanismWhat's in a label? Ecstasy sellers' perceptions of pill brands"Research chemicals": tryptamine and phenethylamine use among high-risk youth.Behavioral effects of MDMA ('ecstasy') on adult zebrafish.Critical role of peripheral vasoconstriction in fatal brain hyperthermia induced by MDMA (Ecstasy) under conditions that mimic human drug useDifferential physiological changes following internet exposure in higher and lower problematic internet users.The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivativesAn in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students.Effects of Repeated Administration of 3,4-methylenedioxymethamphetamine (MDMA) on Avoidance Memory and Cell Density in Rats' Hippocampus.Evidence for significant polydrug use among ecstasy-using college students.Ecstasy-induced thyrotoxic periodic paralysisEcstasy (3,4-methylenedioxymethamphetamine) limits murine gammaherpesvirus-68 induced monokine expression.Acute methamphetamine intoxication: brain hyperthermia, blood-brain barrier, brain edema, and morphological cell abnormalities.Profound hypoglycemia with ecstasy intoxication.Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences.Brain temperature homeostasis: physiological fluctuations and pathological shifts.Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma.Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazardHeat increases MDMA-enhanced NAcc 5-HT and body temperature, but not MDMA self-administration.Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humansElectroencephalographic and convulsive effects of binge doses of (+)-methamphetamine, 5-methoxydiisopropyltryptamine, and (±)-3,4-methylenedioxymethamphetamine in rats.Medical conditions of adolescents in alcohol and drug treatment: comparison with matched controls.Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans.Reduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice.Expression of neuronal trace amine-associated receptor (Taar) mRNAs in leukocytes.Ecstasy (MDMA) Alters Cardiac Gene Expression and DNA Methylation: Implications for Circadian Rhythm Dysfunction in the Heart.The hidden side of drug action: brain temperature changes induced by neuroactive drugs.Environmental conditions modulate neurotoxic effects of psychomotor stimulant drugs of abuse.Signal-averaged electrocardiogram in physically healthy, chronic 3,4-methylenedioxymethamphetamine (MDMA) usersUrinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration.Tri-city study of Ecstasy use problems: a latent class analysis.Successful quantification of 4'-methyl-α-pyrrolidinohexanophenone (MPHP) in human urine using LC-TOF-MS in an autopsy caseSimultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methyleneState-dependent and environmental modulation of brain hyperthermic effects of psychoactive drugs of abuse.Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine.Clinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction.Ecstasy-induced recurrent toxic hepatitis in a young adult.
P2860
Q25256757-4B728441-A524-493F-8600-737D746F334DQ25256989-BCE0A262-DBC5-4F68-89DF-EC37029FF463Q28486143-D0B522E1-5914-4840-ACD9-41259113F81EQ28566274-A8346EA5-7608-4EEE-85D1-25CFBA9EB18EQ28752119-6AC800A0-3940-4885-BF9B-41BC92BDD726Q30368441-544E9784-DF61-41B9-98B2-329759948F1BQ30466934-2D11C05A-9BE5-42F0-8D66-BC442FDDA3FDQ33707843-D957011E-6F2B-4D58-80F3-ACA5EF63EF4BQ33728654-6EB1C691-FF73-47D1-B1BC-7D5141C6DD21Q34112933-D874D181-A85F-4381-A5CA-E05F039DA27DQ34170299-194353B3-DE66-454E-AD0F-69D26AA2CD11Q34368013-3EA6B0E7-2033-43DA-97AC-7E1A976459FEQ34422868-5CBAF5D0-B07C-48AB-9135-AB5AE2DCCFA3Q34525596-42F7DEBD-AC00-4F93-A116-7FD46CDF18AFQ34767737-C082093C-44D4-4CC4-BCFC-257E5E185BFBQ35011779-C6FE2C29-F276-404F-BAE6-81D2447C2087Q35065575-136FCF79-8037-4AF8-8305-D410A80846E7Q35077922-69E3D925-FFF8-4415-9E80-32AC51B3C606Q35146344-EF0583F7-6FF7-485E-9151-AD49B1AFA06FQ35184723-AEFD8BA5-0717-464F-925F-388BE0601640Q35554456-5A3987DB-D0DE-4B98-A7B3-56685FC6E506Q35576531-CE078F1B-6D75-4859-80FA-9D26D987F3B1Q35577713-616B5FC6-2EB6-4F6B-AF5A-F28D647E5E27Q35618891-9296C517-F162-43AD-B288-60C29BF0FE52Q35809624-A7B7451F-7601-4260-9046-096C089E45CAQ35953819-4B08C53A-6B9F-43E2-A5E1-0BDEBCB0E608Q36012329-35C3FCF0-24F7-428B-9E34-AAF6F48923AAQ36357170-7610A008-1095-4ED6-B9EE-73DF72756181Q36515912-5BFA2157-5F19-4421-8C9B-E42250954950Q36572459-E9F5FA4E-218F-45F4-982C-030BF7F4F666Q36942381-872C32BE-3CA8-4C8D-9F88-DA2607A36E1FQ36983273-5A4463C1-27AB-42E6-A958-5B6DC8ADF607Q37029550-69FFE26D-678C-4F33-9706-5268B84F4F38Q37071511-066A97AD-B4E3-4409-95E5-21AC9F0A47DFQ37146920-4E01D725-C925-481A-AA35-F1360094FB47Q37161392-A7C94E9F-5C58-4F1E-8663-200D0700B4D0Q37226593-18199DEE-794C-4D0E-9AD1-EEBCE44874CAQ37417563-8B61EDBE-554F-4395-A9F9-94D06278B359Q37458263-C2A748AB-23A6-4BAD-8F87-74D13698783FQ38559983-518BEEBE-D917-41AC-ABB0-748BAB786E30
P2860
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
@ast
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
@en
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
@nl
type
label
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
@ast
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
@en
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
@nl
prefLabel
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
@ast
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
@en
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
@nl
P2860
P1476
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
@en
P2093
P2860
P304
P407
P577
2001-10-02T00:00:00Z